Is the future of therapy online? Swiss drug giant Novartis thinks so

Can online access to mental health care improve the lives of patients with schizophrenia and multiple sclerosis?

Swiss drug giant Novartis and its executive director of digital therapeutics, Joris Van Dam, say yes.

To develop these kinds of treatments, which are called digital therapeutics and designed to be paired with traditional medications, Novartis NVS, -0.07% announced a partnership with privately-held Pear Therapeutics in March.

The premise is that putting therapy online, where it can be accessed at any time of the day, and standardizing it through an app will improve patient outcomes.

That may sound familiar, as it’s a common refrain about digital products in the health-care space.

>>> Original Source <<<